Birdwatch Note
2022-11-29 18:02:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Presidential candidate Donald Trump explicitly requested and tacitly accepted Russian assistance in winning the 2016 election. https://www.npr.org/2021/03/16/977958302/intelligence-report-russia-tried-to-help-trump-in-2020-election Ivermectin is a veterinary de-wormer that has no effect on COVID-19. https://www.npr.org/2022/03/30/1089809588/ivermectin-covid-treatment-brazil-study
Written by 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1595161056812285953
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1597652313362948097
- noteId - 1597652313362948097
- participantId - 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858
- noteAuthorParticipantId -
- createdAtMillis - 1669744969107
- tweetId - 1595161056812285953
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Presidential candidate Donald Trump explicitly requested and tacitly accepted Russian assistance in winning the 2016 election. https://www.npr.org/2021/03/16/977958302/intelligence-report-russia-tried-to-help-trump-in-2020-election Ivermectin is a veterinary de-wormer that has no effect on COVID-19. https://www.npr.org/2022/03/30/1089809588/ivermectin-covid-treatment-brazil-study
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-11-29 18:02:49 UTC (1669744969107) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858 |
Note Ratings
rated at | rated by | |
2022-12-10 11:50:52 -0600 | 01DBEC84C496A779D4E39289A1AAA0C856FABF1401CB00C44BBB3CEBC27F480B | Rating Details |
2022-11-30 10:36:33 -0600 | 203F486813F1CF7130EB76D890BD43714485D49D589864D5481028127D2D569E | Rating Details |
2022-11-29 12:40:54 -0600 | 22AE3115F75FCFB63BDA723149803A7CC3CFFE2FF870153DFA72FF8965A205FF | Rating Details |
2022-11-29 13:02:24 -0600 | 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 | Rating Details |
2022-11-30 03:15:32 -0600 | 4045C453DDBDEAEC703AC7CDD1FCCAA49743FD0FA98D9190BC401802F4990C4E | Rating Details |
2022-11-30 01:43:04 -0600 | 547B46B38A1CB3060240F9F561852ADB212E08AA27CDAE1D9BE8DDCD9A5D2518 | Rating Details |
2022-12-02 17:47:38 -0600 | 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 | Rating Details |
2022-11-29 12:44:50 -0600 | 70C181B24233FF8251A370E67F314FF2678F046BCC2BD211A42D44AC787BC7DC | Rating Details |
2022-11-29 19:30:56 -0600 | 75640F2D508337E7439D9B45BDCB4BDC2EA68A177E4596486D33A667FA183DCD | Rating Details |
2022-11-30 11:24:16 -0600 | 7BD0400C81C023A216961124BAA56A5AD5E66E315C72382F8D9B9F5908924672 | Rating Details |
2022-11-29 21:16:35 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
2022-11-29 12:51:02 -0600 | 805341F2454AAE7F01B4D57DC54C7C39FA36B5E1EF7FA7ED70F33F84C6C471C2 | Rating Details |
2022-11-30 21:27:56 -0600 | 96259C16C38458FE7A8A6C293A8049357F7D3EC2D0F557E58FD8034ED6400C1F | Rating Details |
2022-11-29 23:25:28 -0600 | 999732EF8B9E55453D2D29E9EB438EA6354F1EA8E0B5987EC90C1823A790B553 | Rating Details |
2022-11-30 12:13:24 -0600 | A6706C9E1EE61DDA58847C2ACBE535C663BA583C6BB50C9326A09022B090B683 | Rating Details |
2022-11-29 13:08:58 -0600 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2022-11-29 18:49:27 -0600 | AA666C86270B66AFD57DA5384BEA3E6506A9771CE51322EF624604E00E0CA72B | Rating Details |
2022-11-29 15:07:14 -0600 | ADD6D84E1F57E6163E655F2B417E4696E606ADB54DD1EDE679CED0D4F3222ABD | Rating Details |
2022-11-29 20:20:57 -0600 | E5829E2688AD3ADEE35B6BB9FA1373E051069848644BCBC53CA82AE5190BCA20 | Rating Details |
2022-11-29 22:10:14 -0600 | E91E7510DF65DF36C923368403BD32781E3143AFB29F606CDA831ABC96F5D437 | Rating Details |
2022-11-29 13:19:18 -0600 | ED631A047550482645D6AF42E75C31CF2FE81AC9C6220396E1657D510F2C2F7C | Rating Details |
2022-11-29 19:02:47 -0600 | FECED1280CB407CFE64D95D425F93392A3AA35F7901C257C5A49187FDF407E27 | Rating Details |
2022-11-29 15:06:29 -0600 | Rating Details | |
2022-11-29 12:47:48 -0600 | Rating Details | |
2022-11-29 15:49:54 -0600 | Rating Details | |
2022-11-30 12:13:24 -0600 | Rating Details | |
2022-11-29 23:25:28 -0600 | Rating Details | |
2022-11-29 13:19:18 -0600 | Rating Details | |
2022-11-29 19:30:56 -0600 | Rating Details | |
2022-11-29 12:44:50 -0600 | Rating Details | |
2022-11-29 18:49:27 -0600 | Rating Details | |
2022-11-29 15:06:29 -0600 | Rating Details | |
2022-11-29 20:20:57 -0600 | Rating Details | |
2022-11-29 13:08:58 -0600 | Rating Details | |
2022-11-29 22:10:14 -0600 | Rating Details | |
2022-11-29 12:40:54 -0600 | Rating Details | |
2022-12-10 11:50:52 -0600 | Rating Details | |
2022-11-30 21:27:56 -0600 | Rating Details | |
2022-11-29 15:07:14 -0600 | Rating Details | |
2022-11-30 10:36:33 -0600 | Rating Details | |
2022-11-30 03:15:32 -0600 | Rating Details | |
2022-11-29 12:47:48 -0600 | Rating Details | |
2022-11-29 21:16:35 -0600 | Rating Details | |
2022-11-29 13:02:24 -0600 | Rating Details | |
2022-11-30 11:24:16 -0600 | Rating Details | |
2022-11-29 19:02:47 -0600 | Rating Details | |
2022-11-30 01:43:04 -0600 | Rating Details | |
2022-12-02 17:47:38 -0600 | Rating Details | |
2022-11-29 12:51:02 -0600 | Rating Details | |
2022-11-29 15:49:54 -0600 | Rating Details |